Sort
59,101 grants matching “hypertension”
The Cellular Response to Elafin in PAH
$701,561Marlene Rabinovitch · Stanford University · P01 · FY2020 · HL
The Cellular Response to Elafin in PAH
$701,561Marlene Rabinovitch · Stanford University · P01 · FY2021 · HL
The Cellular Response to Elafin in PAH
$701,561Marlene Rabinovitch · Stanford University · P01 · FY2018 · HL
The Cellular Response to Elafin in PAH
$701,561Marlene Rabinovitch · Stanford University · P01 · FY2017 · HL
Caveolar Defects Underlie the Genetic Origins of PAH
$701,513James E Loyd · Vanderbilt University · R01 · FY2013 · HL
Image-guided Planning System for Skull Correction in Children with Craniosynostosis: Phase II
$701,499Marius George Linguraru · Kitware, Inc. · R42 · FY2017 · HD
Resistin regulates NLRP3 inflammasome in pulmonary hypertension
$701,467Roger A Johns · Johns Hopkins University · R01 · FY2023 · HL
Testing the Efficacy of a Technology-Assisted Weight Management Intervention within Patient-Centered Medical Homes: The GEM (Goals for Eating and Moving) Study
$701,455Melanie Jay · New York University School Of Medicine · R01 · FY2019 · DK
Anion channel regulation of vascular superoxide signaling in hypertension
$701,434Fred S Lamb · Vanderbilt University Medical Center · R01 · FY2025 · HL
The Aging Kidney Anatomy Study
$701,410Andrew D Rule · Mayo Clinic Rochester · R01 · FY2017 · DK
The Aging Kidney Anatomy Study
$701,410Andrew D Rule · Mayo Clinic Rochester · R01 · FY2019 · DK
The Aging Kidney Anatomy Study
$701,410Andrew D Rule · Mayo Clinic Rochester · R01 · FY2018 · DK
Renal endothelin receptor-specific function in angiotensin ll-dependent hypertens
$701,383David M Pollock · Augusta University · P01 · FY2011 · HL
Randomized Trial of a Healthy Weight Intervention for Youth with Serious Emotional Disturbance
$701,352Gail L Daumit · Johns Hopkins University · R01 · FY2019 · MH
Postdoctoral Training in Arteriosclerosis Research
$701,240Henry N Ginsberg · Columbia University Health Sciences · T32 · FY2023 · HL
A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
$701,223Benjamin G Druss · Emory University · R01 · FY2014 · MH
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors
$701,204Rebecca Maureen Howell · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Structure and Function of Non-Conventional Caveolins
$701,173Anne K Kenworthy · University Of Virginia · R01 · FY2024 · HL
Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension
$701,157Di Feng · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
Novel Ultrasound Indices of Intracranial Pressure and Brain Ischemia in Neonatal Hydrocephalus
$701,154Misun Hwang · Children'S Hosp Of Philadelphia · R01 · FY2025 · NS
Targeting cardiovascular events to improve patient outcomes after sepsis
$701,112Allan J. Walkey · Boston University Medical Campus · R01 · FY2019 · HL
Characterization of Coagulation Factor-platelet Interactions: Role of FXI
$701,086Owen J McCarty · Oregon Health & Science University · R01 · FY2022 · HL
Assessment of Policies through Prediction of Long-term Effects on Cardiovascular Disease Using Simulation (APPLE CDS)
$701,082Bian Liu · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · HL
Genetic Studies of The Impact of Hematologic Traits On Cardiovascular Disease
$701,071Santhi K Ganesh · University Of Michigan At Ann Arbor · R01 · FY2018 · HL
An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hyper
$701,052Lawrence S. Zisman · Pulmokine, Inc. · R44 · FY2013 · HL